Needham Reiterates Buy Rating on AtriCure Inc. (ATRC)

May 6, 2026 6:16 AM

Needham analyst Mike Matson reiterated a Buy rating and $45.00 price target on AtriCure Inc. (NASDAQ: ATRC).The analyst commented: "ATRC's ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found